Minagawa, K., Jamil, M. O., Al-Obaidi, M., Pereboeva, L., Salzman, D., Erba, H. P., … Di Stasi, A. (2017). Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia. PLoS One, 12(2), e0172640. https://doi.org/10.1371/journal.pone.0172640

Minagawa, Kentaro, Muhammad O. Jamil, Mustafa Al-Obaidi, Larisa Pereboeva, Donna Salzman, Harry P. Erba, Lawrence S. Lamb, Ravi Bhatia, Shin Mineishi, and Antonio Di Stasi. “Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.” PLoS One 12, no. 2 (2017): e0172640. https://doi.org/10.1371/journal.pone.0172640.

Minagawa K, Jamil MO, Al-Obaidi M, Pereboeva L, Salzman D, Erba HP, et al. Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia. PLoS One. 2017;12(2):e0172640.

Minagawa, Kentaro, et al. “Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.” PLoS One, vol. 12, no. 2, 2017, p. e0172640. Pubmed, doi:10.1371/journal.pone.0172640.

Minagawa K, Jamil MO, Al-Obaidi M, Pereboeva L, Salzman D, Erba HP, Lamb LS, Bhatia R, Mineishi S, Di Stasi A. Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia. PLoS One. 2017;12(2):e0172640.